US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
570 companies in Healthcare · page 6 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Biotricity Inc. (BTCY) | Healthcare | $995,700pit | $16.0M | 16.0% | -15.0% | — | — | — |
| Relay Therapeutics, Inc. (RLAY) | Healthcare | $3.57Bpit | $15.4M | 53.4% | — | -48.8% | — | — |
| Allurion Technologies, Inc. (ALUR) | Healthcare | $288,634vendor | $15.2M | -52.6% | — | — | — | — |
| Vsee Health, Inc. (VSEE) | Healthcare | $1.5Mvendor | $14.6M | 40.3% | — | -269.8% | — | — |
| Opus Genetics, Inc. (IRD) | Healthcare | $317.8Mpit | $14.2M | 29.1% | — | -323.1% | — | — |
| Arbutus Biopharma Corp (ABUS) | Healthcare | $832.9Mpit | $14.1M | 128.2% | — | -43.7% | — | — |
| Pyxis Oncology, Inc. (PYXS) | Healthcare | $140.1Mpit | $13.9M | -14.2% | — | -149.1% | — | — |
| CV Sciences, Inc. (CVSI) | Healthcare | $2.3Mpit | $13.8M | -12.2% | -6.9% | -65.3% | — | — |
| Lineage Cell Therapeutics, Inc. (LCTX) | Healthcare | $252.9Mpit | $13.6M | 67.0% | — | -146.6% | — | — |
| Hyperfine, Inc. (HYPR) | Healthcare | $82.1Mpit | $13.6M | 5.2% | — | -86.8% | — | — |
| CapsoVision, Inc (CV) | Healthcare | $340.3Mpit | $13.6M | 15.3% | — | -190.9% | — | — |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | Healthcare | $103.6Mpit | $13.1M | 29.8% | — | -50.6% | — | — |
| Nano-X Imaging Ltd. (NNOX) | Healthcare | $29.3Mvendor | $13.0M | 15.4% | — | -53.7% | — | — |
| Evommune, Inc. (EVMN) | Healthcare | $185.1Mpit | $13.0M | 85.7% | — | -33.5% | — | — |
| Escalon Medical Corp. (ESMC) | Healthcare | $1.3Mpit | $12.7M | 5.7% | 31.5% | 67.7% | — | — |
| Emmaus Life Sciences, Inc. (EMMA) | Healthcare | $4.5Mpit | $12.5M | -25.2% | -60.2% | — | — | — |
| Elutia Inc. (ELUT) | Healthcare | $35.9Mpit | $12.3M | -15.0% | — | 192.9% | — | — |
| Prelude Therapeutics Inc (PRLD) | Healthcare | $260.2Mpit | $12.1M | 73.4% | — | -145.0% | — | — |
| Cardiff Lexington Corp (CDIX) | Healthcare | $469,121pit | $11.5M | 39.5% | -47.7% | — | — | — |
| Jaguar Health, Inc. (JAGX) | Healthcare | $4.0Mvendor | $11.5M | -1.5% | — | — | — | — |
| LogicMark, Inc. (LGMK) | Healthcare | $1.2Mvendor | $11.4M | 15.4% | -65.4% | — | — | — |
| Nexgel, Inc. (NXGL) | Healthcare | $2.5Mvendor | $11.4M | 31.5% | -26.3% | -61.3% | — | — |
| Caribou Biosciences, Inc. (CRBU) | Healthcare | $58.4Mpit | $11.2M | 11.7% | — | -121.2% | — | — |
| Crescent Biopharma, Inc. (CBIO) | Healthcare | $488.1Mpit | $10.8M | — | — | -75.8% | — | — |
| TScan Therapeutics, Inc. (TCRX) | Healthcare | $15.2Mpit | $10.3M | 266.7% | — | -105.4% | — | — |
| Alpha Cognition Inc. (ACOG) | Healthcare | $181.0Mpit | $10.2M | — | — | -33.1% | — | — |
| Janux Therapeutics, Inc. (JANX) | Healthcare | $1.02Bpit | $10.0M | -5.6% | — | -11.9% | — | — |
| Zenas BioPharma, Inc. (ZBIO) | Healthcare | $1.62Bpit | $10.0M | 100.0% | — | -156.0% | — | — |
| WORK Medical Technology Group LTD (WOK) | Healthcare | $5.1Mvendor | $9.8M | -14.4% | -10.9% | -5.1% | — | — |
| Taysha Gene Therapies, Inc. (TSHA) | Healthcare | $1.18Bpit | $9.8M | 17.3% | — | -44.1% | — | — |
| Prothena Corp. Public Ltd. Co. (PRTA) | Healthcare | $421.0Mpit | $9.7M | -92.8% | — | -87.0% | — | — |
| Curis Inc. (CRIS) | Healthcare | $846,272pit | $9.4M | -13.4% | -80.3% | -138.8% | — | — |
| Aspira Women's Health Inc. (AWHL) | Healthcare | $9.8Mpit | $9.2M | 0.4% | — | — | — | — |
| Roivant Sciences Ltd. (ROIV) | Healthcare | $26.36Bpit | $8.3M | -71.6% | — | -5.7% | — | — |
| Aclaris Therapeutics, Inc. (ACRS) | Healthcare | $563.8Mpit | $7.8M | -58.2% | — | -63.0% | — | — |
| Adagene Inc. (ADAG) | Healthcare | $163.8Mvendor | $7.7M | 7332.8% | — | — | — | — |
| Whitehawk Therapeutics, Inc. (WHWK) | Healthcare | $164.8Mpit | $7.1M | -72.5% | — | -15.1% | — | — |
| Immunome Inc. (IMNM) | Healthcare | $2.04Bpit | $6.9M | -23.2% | — | -33.5% | — | — |
| Fate Therapeutics Inc. (FATE) | Healthcare | $250.4Mpit | $6.6M | -51.2% | — | -65.8% | — | — |
| Kyntra Bio, Inc. (KYNB) | Healthcare | $18.5Mpit | $6.4M | -78.3% | — | — | — | — |
| DBV Technologies S.A. (DBVT) | Healthcare | $612.8Mvendor | $5.6M | 35.8% | — | -87.1% | — | — |
| Scientific Industries Inc. (SCND) | Healthcare | $8.2Mpit | $5.1M | 5.4% | -24.1% | -11.4% | — | — |
| NewGenIvf Group Ltd (NIVF) | Healthcare | $1.7Mvendor | $4.7M | -13.0% | — | 38.0% | — | — |
| ProPhase Labs, Inc. (PRPH) | Healthcare | $155,926pit | $4.3M | -35.8% | — | -420.3% | — | — |
| CRISPR Therapeutics AG (CRSP) | Healthcare | $4.84Bpit | $3.5M | -90.6% | — | -30.3% | — | — |
| Surrozen, Inc. (SRZN) | Healthcare | $275.5Mpit | $3.5M | -67.4% | — | — | — | — |
| Cartesian Therapeutics, Inc. (RNAC) | Healthcare | $189.7Mpit | $2.8M | -92.8% | — | — | — | — |
| CollPlant Biotechnologies Ltd (CLGN) | Healthcare | $6.8Mvendor | $2.4M | 360.4% | — | -188.9% | — | — |
| Lipocine Inc. (LPCN) | Healthcare | $11.9Mpit | $2.0M | -82.3% | — | -66.5% | — | — |
| Neuphoria Therapeutics Inc. (NEUP) | Healthcare | $18.6Mpit | $1.2M | -92.5% | — | -54.7% | — | — |
| Silence Therapeutics plc (SLN) | Healthcare | $410.1Mpit | $559,000 | -98.7% | — | -142.2% | — | — |
| Mereo BioPharma Group plc (MREO) | Healthcare | $45.0Mpit | $500,000 | — | — | -102.4% | — | — |
| Lite Strategy, Inc. (LITS) | Healthcare | $36.2Mpit | $267,000 | -74.0% | — | -170.9% | — | — |
| Connect Biopharma Holdings Ltd (CNTB) | Healthcare | $50.3Mpit | $64,000 | -99.8% | — | -132.2% | — | — |
| Amylyx Pharmaceuticals, Inc. (AMLX) | Healthcare | $3.23Bpit | $0 | -100.0% | — | -47.4% | — | — |
| Artiva Biotherapeutics, Inc. (ARTV) | Healthcare | $288.0Mpit | $0 | -100.0% | — | -76.3% | — | — |
| Barinthus Biotherapeutics plc. (BRNS) | Healthcare | $30.2Mvendor | $0 | -100.0% | — | -89.4% | — | — |
| Capricor Therapeutics, Inc. (CAPR) | Healthcare | $341.9Mpit | $0 | -100.0% | — | -34.4% | — | — |
| Denali Therapeutics Inc. (DNLI) | Healthcare | $2.88Bpit | $0 | — | — | -50.6% | — | — |
| Fulcrum Therapeutics, Inc. (FULC) | Healthcare | $280.8Mpit | $0 | -100.0% | — | -21.5% | — | — |
| Kiora Pharmaceuticals Inc. (KPRX) | Healthcare | $10.1Mpit | $0 | -100.0% | — | -67.2% | — | — |
| Revolution Medicines, Inc. (RVMD) | Healthcare | $40.08Bpit | $0 | — | — | -69.3% | — | — |
| Spruce Biosciences, Inc. (SPRB) | Healthcare | $114.0Mpit | $0 | -100.0% | — | -91.7% | — | — |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | Healthcare | $158.4Mpit | $0 | -100.0% | — | -63.4% | — | — |
| Contineum Therapeutics, Inc. (CTNM) | Healthcare | $318.3Mpit | — | — | — | -23.0% | — | — |
| Equillium, Inc. (EQ) | Healthcare | $80.5Mpit | — | — | — | -78.3% | — | — |
| Maze Therapeutics, Inc. (MAZE) | Healthcare | $1.77Bpit | — | — | — | -36.9% | — | — |
| Palvella Therapeutics, Inc. (PVLA) | Healthcare | $1.80Bpit | — | — | — | -149.1% | — | — |
| Tvardi Therapeutics, Inc. (TVRD) | Healthcare | $13.5Mpit | — | — | — | -87.0% | — | — |
| Veru Inc. (VERU) | Healthcare | $39.2Mpit | — | — | — | -124.0% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.